SRRK Q4 2024 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$5B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$395,000

Operating Income

-$69M

Net Income

-$66M

EPS (Diluted)

$-0.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$50M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$475M

Total Liabilities

$106M

Stockholders' Equity

$369M

Cash & Equivalents

$178M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$395,000	-$672,000	+41.2%
Operating Income	-$69M	-$48M	-44.4%
Net Income	-$66M	-$46M	-44.1%